Gamma Knife Market Growth Analysis By Top Major Players

Gamma Knife Market is anticipated to driven by increasing prevalence of various types of cancer, increasing preference toward non- and minimally-invasive procedures, high adoption and acceptance in developed markets.

Gamma knife is an advanced radiation therapy for the treatment of cancer in adults and children. Gamma knife is not really a knife; it is a beam of highly focused gamma rays, to precisely cut or destroy the tumor or damaged cells, generally in the brain, causing little or no damage to the surrounding normal cells. Gamma knife technology is used to treat medium brain tumors, trigeminal neuralgia, epilepsy, nerve disorders that causes chronic pain, abnormal blood vessel formations called arteriovenous malformations, and other neurological conditions. Patients with serious diseases can be treated with the help of this technology which is a noninvasive procedure and get cured in a few days with no long hospital stay, returning to normal life and activity promptly. Typically, gamma knife treatment is completed in a few hours with little or no side effects. According to Leksell Gamma Knife Society, gamma knife technology is universally preferred and no other radiosurgery system has greater clinical acceptance as gamma knife. Gamma knife radiosurgery is performed in leading hospitals around the world, with more than 70,000 patients treated every year. To treat with gamma knife technology the surgeon neither requires to make an incision in the scalp, nor an opening in the skull.

The gamma knife market can be segmented by disease indication and geography. Based on disease indication, the market is classified into cancer, arteriovenous malformation (AVM), trigeminal neuralgia, essential tremor and others (epilepsy, Parkinson’s disease etc.). Cancer holds the dominant share of the gamma knife market by disease indication, and its increasing prevalence is expected to boost the overall market. There are over 100 types of cancer. According to WHO, about 16% of the world population die because of cancer. In 2015, 8.8 million people died of cancer. This is expected to be the prominent driver for the gamma knife market.

Geographically, the gamma knife market is classified into five regions, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America has the leading market share followed by the other developed region, Europe. The U.S. accounts for a major share of the global market. According to the American Cancer Society, in 2016, about 1,685,210 new cancer cases were diagnosed. Advanced technologies, high awareness levels, and high purchasing power in North America influenced the gamma knife technology market expansion significantly. However, the same factor of affordability has restrained the markets in developing regions. Despite this, the gamma knife market in Asia Pacific has shown significant increase in growth rate. Rising population, increase in disposable income, increase in the geriatric population, and increase in awareness levels are some key factors driving the Asia Pacific market. Due to these factors, the Asian market is observing a large number of new entrants compared to developed regions.

Other factors that drive the gamma knife market are increasing prevalence of various types of cancer, increasing preference toward non- and minimally-invasive procedures, high adoption and acceptance in developed markets, high success rate of gamma knife procedure, innovations and developments in technology, and comprehensive health insurance cover for radio surgery procedures. The market is also experiencing certain restraints such as stiff competition among existing players, high cost of the procedure, low equipment availability, and lack of awareness about gamma knife therapy among the rural population in developing and underdeveloped economies.

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

The global coronary stents market at US$7.4 bn in 2012. Although the market witnessed a slight dip in its overall value in 2013, when it reached US$6 bn, by 2019, analysts expect the market to reach US$8.3 bn.

Audiological devices market is witnessing expansion at a relatively higher growth rate owing to the increasing geriatric population, adoption of audiological devices due to rising number of cases of hearing loss, and surge in research and development in both developed and developing markets.

The low cost of rapid tests is the primary reason behind the astral growth of the global market for rapid test. Furthermore, the favourable operational dynamics of rapid tests have also emerged as a key factor contributing towards the growth of the global rapid test market.

Increase in the number of cardiovascular disorders drives the global Holter ECG monitor market. Furthermore, technological advancements are anticipated to boost the growth of the market in the next few years.

The global sterile injectable drugs market is expected to expand at a CAGR of 11.1% between 2017 and 2025 to secure a valuation of US$901.3 bn by the completion of the forecast tenure. In 2017, the market accomplished a valuation of US$387.1 bn.

High incidence of ocular disorders such as dry eyes, acne rosacea, and demodex infestation; rise in patient awareness, increase in research and development initiatives, and the advent of high-throughput screening (HTS) for drug discovery for ocular diseases are key factors driving the blepharitis treatment market.

Asia-Pacific is one of the most lucrative markets for the growth of dental pain market and is developing at a rapid rate.This research report analyzes this market on the basis of its market segments, major geographies, and current market trends

Inclusion body myositis (IBM) is an age related muscle disorder, which is most common among aged individuals and it may lead to severe disability due to its incurable nature.This research report analyzes this market on the basis of its market segments, major geographies, and current market trends.

Global lithotripsy device market was valued at US$ 705.5 Mn in 2017 and is projected to reach US$ 984.3 Mn by 2026, expanding at a CAGR of 3.8% from 2018 to 2026. Rise in prevalence of gallstone and kidney stone diseases is anticipated to drive the global market.

The growing use of high quality CT imaging in modern healthcare in various parts of the world is a key trend bolstering the demand for radiation dose-reduction systems. The growing awareness of physicians and technologists dose reduction methods and factors is a key factor boosting the radiation dose-reduction system market.

The rising demand for novel therapeutic devices for a wide spectrum of clinical conditions, including cardiovascular and cancer diseases, is a key trend bolstering the demand for image-guided therapy systems market

Healthcare industry of a country or region plays a vital role in deciding the overall growth of the economy. For this reason, governments and regional leaders have been giving utmost importance to the betterment of healthcare facilities. Hence, the demand within the global healthcare reimbursement market has reached new heights in recent times.

Rising research activities by several pharmaceutical and biotechnology companies, especially in developing and developed countries, with the aim of finding treatments for chronic diseases is bolstering the demand for pipettes and accessories market

The global nuclear medicine market mainly due to the high quality of services offered, greater innovations and their increased reliability.This research report analyzes this market on the basis of its market segments, major geographies, and current market trends.

Anti-adhesion products market is foreseen to collect strong growth prospects while riding on the growing occurrence of postsurgical adhesive diseases and their clinical ramifications and unwanted patient outcomes

A cardiac MRI is used to monitor or detect any heart-related abnormality or defect. Major factors driving the cardiac MRI testing market include increase in the prevalence of heart diseases globally, rise in the geriatric population, and technological advancements.

Global life science instrumentation market is projected to reach US$ 90 Bn by 2027, expanding at a single digit CAGR during the forecast period. Rise in prevalence and incidence rates of infectious diseases

Thyroid function test market is anticipated to exceed a value of US$ 2.4 Bn by 2027, expanding at a CAGR of more than 5% from 2019 to 2027. The market is driven by an increase in the incidence of thyroid disease

Major factors to propel the global IoT medical devices market are the growing need for cost efficient services in healthcare and medical sector for patients. The increase in the number of new hospital and medical center set-ups are also creating more opportunities of growth in the years to come.

The market for blood testing is also growing owing to burgeoning demand for point of care testing.This research report analyzes this market depending on its market segments, major geographies, and current market trends.